COGN3-BZ

COGN3-BZ

COGN3-BZ

Letters With This Ticker

Quarter Letter Date Fund Name QTD YTD Tickers Keywords/Themes Theme Commentary Pitches Letter
2017 Q4 Dec 31, 2017 Aquamarine - 34.9% ATGE, BRK/A, COGN3 BZ, COST, FCAU, GM, RACE IM, SCHW, TSLA -

Pitches With This Ticker

Date Pitch Type Author Company Industry Sub Industry Bull / Bear Stock Exchange Keywords Action
Apr 28, 2026 Fund Letters The Sound Shore Fund Organon & Co Health Care Pharmaceuticals Bull NYSE cash flow generation, debt reduction, healthcare, pharmaceuticals, R&D pipeline, spinoff, Value, women's health
Apr 28, 2026 Fund Letters The Sound Shore Fund Organon & Co Health Care Pharmaceuticals Bull NYSE cash generation, high dividend yield, pharmaceuticals, R&D pipeline, spinoff, Value Investment, women's health

BSD Shareholders of COGN3-BZ

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025
Manager Name Fund Name Fund AUM Invested Value Portfolio Weight Shares Owned Shares Bought / Sold During Quarter % Bought / Sold During Quarter % of Shares Outstanding Owned
No investor data available.